Skip to content

In the BioHarmony Drug Report Database

Prochlorperazine

Compazine (prochlorperazine) is a small molecule pharmaceutical. Prochlorperazine was first approved as Compazine on 1982-01-01. It is used to treat anxiety disorders, dementia, nausea, psychotic disorders, and schizophrenia amongst others in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. In addition, it is known to target D(1A) dopamine receptor, D(4) dopamine receptor, and protein S100-A4.
Trade Name Compazine
Common Name Prochlorperazine
Indication anxiety disorders, dementia, nausea, psychotic disorders, schizophrenia, vomiting
Drug Class Typical antipsychotic
Prochlorperazine
Get full access now